Protein arrays and pattern recognition: New tools to assist in the identification and management of autoimmune disease

Autoimmunity Reviews

Volumn 5, Issue 4, 2006, Pages 234-241

  Binder, Steven R ^a   Hixson, Craig ^a   Glossenger, John ^a  

^a BIO RAD LABORATORIES   (United States)

Author keywords

Autoantibodies; Expert systems; Nearest neighbor; Pattern recognition; Protein arrays

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; MICROSPHERE;

ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; CLINICAL EXAMINATION; COMPUTER ANALYSIS; COMPUTER PROGRAM; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; DNA MICROARRAY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERT SYSTEM; HUMAN; IMMUNODIFFUSION; MATHEMATICAL COMPUTING; PROTEIN MICROARRAY; REPRODUCIBILITY; REVIEW; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ALGORITHMS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; HUMANS; PATTERN RECOGNITION, AUTOMATED; PROTEIN ARRAY ANALYSIS;

EID: 33646377150     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2005.07.007     Document Type: Review

References (40)

1. Sharp G.C., Irvin W.S., LaRoque R.L., et al. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 50 (1971) 350-359
2. Notmann D.D., Kurata N., and Tan E.M. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 83 (1975) 464-469
3. Schmitt J., and Papisch W. Recombinant antigens. Autoimmun Rev 1 (2002) 79-88
4. Robinson W.H., Steinman L., and Utz P.J. Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics 3 (2003) 2077-2084
5. Ekins R.P., and Chu F.W. Multianalyte microspot immunoassay-microanalytical "compact disk" of the future. Clin Chem 37 (1991) 1955-1967
6. Joos T.O., Schrenk M., Hopfl P., et al. A microarray enzyme-linked immunosorbent assay for diagnostics. Electrophoresis 21 (2000) 2641-2650
7. Robinson W.H., DiGennaro C., Hueber W., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8 (2002) 295-331
8. Feng Y., Ke X., Chen Y., Hu G., and Liu F. Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin Chem 50 (2004) 416-422
9. Martens T.B., Burlingame R., von Muhlen C.A., Jackowski T.D., Litwin C.M., and Hill H.R. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 11 (2004) 1054-1059
10. Gilburd B., Abu-Shakra M., Shoenfeld Y., et al. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation-a homogenous multiplexed system. Clin Dev Immunol 11 (2004) 53-56
11. Buliard A., Fortenfant F., Ghillani-Dalbin P., et al. Analysis of nine autoantibodies associated with systemic autoimmune diseases using the Luminex technology. Results of a multicenter study. Ann Biol Chem 63 (2005) 51-58
12. Shovman O., Gilburd B., Barzilai O., et al. Evaluation of the BioPlex™2200 ANA Screen. Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies. Ann New York Acad Sci 1050 (2005) 380-388
13. Xiang Y., Sekine T., Nakamura H., et al. Proteomic surveillance of autoimmunity in osteoarthritis. Arthritis Rheum 50 (2004) 1511-1521
14. Sinz A., Bantscheff M., Mikkat S., et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 23 (2002) 3445-3456
15. Drynda S., Ringel B., Kekow M., et al. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with a potential to monitor anti-TNFα therapy. Pathol Res Pract 200 (2004) 165-171
16. Payne T.H. Computer decision support systems. Chest 18 (2000) 47S-52S
17. Dreiseitl S., and Binder M. Do physicians value decision support? A look at the effect of decision support systems on physician opinion. Artif Intell Med 33 (2005) 25-30
18. Moens H.J., and van der Korst J.K. Computer-assisted diagnosis of rheumatic disorders. Semin Arthritis Rheum 21 (1991) 156-169
19. Innis M.D. Clinical problem solving-the rule of expert laboratory systems. Med Inform 22 (1997) 251-262
20. Porter J.F., Kingsland L.C., Lindberg D.A.B., et al. The AI/RHEUM knowledge-based computer consultant system in rheumatology. Arthritis Rheum 31 (1988) 219-226
21. Athreya B.H., Cheh M.L., and Kingsland III L.C. Computer-assisted diagnosis of pediatric rheumatic diseases. Pediatr 102 (1998) 1-7
22. Kolarz G., Adlassnig K.P., and Bogl K. RHEUMexpert: medical documentation and knowledge-based decision support in rheumatology. Wien Med Wochenschr 149 (1999) 572-574
23. Schewe S., and Schreiber M.A. Stepwise development of a clinical expert system in rheumatology. J Clin Invest 71 (1993) 139-144
24. Moens H.J., and van der Korst J.K. Development and validation of a computer program using Bayes's theorem to support diagnosis of rheumatic disorders. Ann Rheum Dis 51 (1992) 266-271
25. Sharpe P.K., and Caleb P. Artificial neural networks within medical decision support systems. Scand J Clin Lab Invest 219 (1994) 3-11 [suppl]
26. Astion M.L., Block D.A., and Wener M.H. Neural networks as expert systems in rheumatic disease diagnosis: artificial intelligence or intelligent artifice?. J Rheumatol 20 (1993) 1465-1468
27. Astion M.L., Wener M.H., Thomas R.G., Hunder G.G., and Bloch D.A. Application of neural networks to the classification of giant cell arteritis. Arthritis Rheum 37 (1994) 760-770
28. Rajimeh R., Farsiu S., and Kouhsari L.M. Prediction of lupus nephritis in patients with systemic lupus erythematosus using artificial neural networks. Lupus 11 (2002) 485-492
29. Grus F.H., and Zimmermann C.W. Identification and classification of autoantibody repertoires (Western blots) with a pattern recognition algorithm by an artificial neural network. Electrophoresis 18 (1997) 1120-1125
30. Stone J.H., Rajapakse V.N., Hoffman G.S., et al. A serum proteomic approach to gauging the state of remission in Wegener's Granulomatosis. Arthritis Rheum. 52 (2005) 2168-2178
31. Quintara F.J., Hagedorn P.H., Elizur G., Merbl Y., Domany E., and Cohen I.R. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A 101 (2004) 14615-14621
32. Subcebe G., and Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Clin Exp Rheumatol 10 (1992) 255-261
33. Villarreal G.M., Drenkard C., Villar A.R., et al. Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity. Lupus 6 (1997) 425-435
34. Cervara R., Khamashta M.A., Font J., et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine 72 (1993) 113-124
35. Hoffman I.E., Peene I., Meheus L., et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63 (2004) 1155-1158
36. Arbuckle M.R., McClain M.T., Rubertone M.V., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349 (2003) 1526-1533
37. Scofield R.H. Autoantibodies as predictors of disease. Lancet 363 (2004) 2544-2546
38. Binder SR, Genovese M, Merrill JA et al, manuscript submitted to Clinical and Diagnostic Laboratory Immunology.
39. Wyns B., Sette S., Boullart L., Baeten D., Hoffman I.E., and De Keyser F. Prediction of diagnosis in patients with early arthritis using a combined Kohonen mapping and instance-based evaluation criterion. Artif Intell Med 31 (2004) 45-55
40. Simón J.A., Cabiedes J., Ortiz E., Alcocer-Velera J., and Sánchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosis of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 43 (2004) 220-224